Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
104.985 USD
-0.86%
Market Closed
Updated:
Apr 18, 2024
Abbott Laboratories
Total Current Liabilities
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbott Laboratories
Total Current Liabilities Peer Comparison
Comparables:
BDX
BSX
EW
SYK
ISRG
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Total Current Liabilities
$13.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Total Current Liabilities
$7.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
14%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Current Liabilities
$4.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
10%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Total Current Liabilities
$1.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
13%
|
|
|
Stryker Corp
NYSE:SYK
|
Total Current Liabilities
$7.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
12%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Current Liabilities
$1.7B
|
CAGR 3-Years
20%
|
CAGR 5-Years
15%
|
CAGR 10-Years
16%
|
See Also
What is Abbott Laboratories's Total Current Liabilities?
Total Current Liabilities
13.8B
USD
13.8B
USD
Based on the financial report for Dec 31, 2023, Abbott Laboratories's Total Current Liabilities amounts to 13.8B USD.
What is Abbott Laboratories's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
4%
4%
Over the last year, the Total Current Liabilities growth was -11%. The average annual Total Current Liabilities growth rates for Abbott Laboratories have been 5% over the past three years , 9% over the past five years , and 4% over the past ten years .
You don't have any saved screeners yet
